Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001780088-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-15 | STOK | Ticho Barry | Chief MEDICAL Off | M - OptEx | $0.00 | +33.9K | 42.9K | +374% | $0 |
| DM | 2026-03-17 | 2026-03-15 | STOK | Ticho Barry | Chief MEDICAL Off | M - OptEx | $0.00 | -33.9K | 32.2K | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | M | A | 10,750 | $0.00 | 53,648 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-15 | M | A | 13,100 | $0.00 | 32,898 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-15 | M | A | 10,000 | $0.00 | 42,898 | D | — | — | |
| 4 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 13,100 | $0.00 | 13,100 | D | — · — to 2027-03-15 | 13,100 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F2) The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date. |
| 5 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 10,000 | $0.00 | 20,000 | D | — · — to 2028-03-15 | 10,000 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F3) The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the Issuer through each vesting date. |
| 6 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 10,750 | $0.00 | 32,250 | D | — · — to 2029-03-15 | 10,750 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F4) The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date. |